Articles by Renaissance Capital

Israeli ADHD drug developer Alcobra files for a $17 million IPO

Alcobra, a biopharmaceutical company focused on the development of a drug to treat ADHD, filed on Monday with the SEC to raise up to $17 million in an initial public offering. The Tel... Read >>

Weekly recap: 2013 US IPO calendar builds quickly

Throughout the past decade, US IPO pricings have fallen in January after heavy end-of-the-year activity, but 2013 appears likely to break the trend. Following December's four pricings, nine... Read >>

Bain's Bright Horizons sets terms for IPO that could raise $200 million

Bright Horizons Family Solutions, which is a leading provider of work site child care and early education centers, announced terms for its IPO on Monday. The Watertown, MA-based company plans... Read >>

5 US IPOs planned for the week of Jan 14

The following IPOs are expected to price this week : CVR Refining, LP ( CVRR ), a limited partnership with petroleum refining operations in Kansas and Oklahoma, plans to raise $500... Read >>

New Jersey bank ConnectOne Bancorp files for a $58 million IPO

ConnectOne Bancorp, a bank primarily serving northeastern New Jersey, filed on Friday with the SEC to raise up to $58 million in an initial public offering. The bank recently changed its from... Read >>

Money transfer service provider Xoom files for a $50 million IPO

Xoom, which provides online consumer-to-consumer international money transfer services, filed on Friday with the SEC to raise up to $50 million in an initial public offering. The San... Read >>

Diagnostic company LipoScience sets terms for $70 million IPO

LipoScience, which provides an LDL diagnostic test to assess cardiovascular disease risk, announced terms for its IPO on Thursday. The Raleigh, NC-based company plans to raise $70 million by... Read >>

REIT ZAIS Financial files for a $140 million IPO

ZAIS Financial, a REIT that invests in agency and non-agency RMBS, filed on Wednesday with the SEC to raise up to $140 million in an initial public offering. ZAIS Financial will be... Read >>

Stemline Therapeutics increases proposed IPO deal size

Stemline Therapeutics, a biotech developing treatments that target cancer stem cells and tumor bulk, raised the proposed deal size for its upcoming IPO on Wednesday. The New York,... Read >>

2013 IPO market set to kick off as calendar swells

After a slow holiday week started off the year, IPO activity is picking up steam. Five new deals have launched this week and areĀ  scheduled to price the week of January 14 . The group is... Read >>

Displaying 291-300 of 951
<< first < previous 30 31 32 33 34 40 60 80 next > last >>